Find policies, billing codes, payers, states, and providers
CPT 87661: Trichomonas vaginalis Nucleic Acid Test
Headline: CPT code 87661: Molecular Test for Trichomonas vaginalis Highlights: CPT code 87661 identifies a nucleic acid amplified probe test for Trichomonas vaginalis, a common sexually transmitted infection. This molecular diagnostic code matters nationally as it supports accurate, sensitive detection of infection, informing treatment decisions and public health surveillance. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find: an overview of clinical context and typical sites of service for the test; payer coverage considerations and commonly encountered modifiers; benchmarking context where available; and operational notes relevant to laboratory billing and coding workflows. The publication summarizes utilization and reimbursement themes for laboratories and clinician offices that send specimens to clinical laboratories. Data not available in the input for detailed utilization metrics, associated taxonomies, and ICD-10 pairing is noted where applicable.
Customize your policy alerts
Sign up for cpt 87661 policy alerts
Get alerted when payer policies referencing 87661 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 87661 describes a laboratory test for Trichomonas vaginalis using a nucleic acid amplified probe technique. The procedure is a molecular diagnostic assay performed by a laboratory analyst to detect the presence of Trichomonas vaginalis nucleic acid.
Service Type: Molecular diagnostic testing
Typical Site of Service: Clinical laboratory or hospital laboratory setting